JPMorgan analyst Eric Joseph downgraded IGM Biosciences (NASDAQ: IGMS) from Neutral to Underweight with a price target of $9.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE